Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Inhaled Steroids Reduce Asthma Deaths

By HospiMedica staff writers
Posted on 04 Sep 2000
A large-scale study of 30,569 asthma patients has found that regular use of low-dose inhaled corticosteroids reduced the risk of death. More...
The study, reported in The New England Journal of Medicine (2000;343:332-336), was conducted by researchers at McGill University in Montreal (Canada) and colleagues.

Although steroids have been widely used to reduce inflammation in the airways of asthma patients, little has been known about their influence on mortality. In the current study, the researchers tracked asthma patients, five through 44 years of age, who were using antiasthma drugs during the period from 1975 through 1991, following the subjects to the end of 1997. About 93% of the prescribed canisters of inhaled corticosteroids contained low-dose beclomethasone. The researchers found that the rate of death from asthma among users of inhaled steroids as compared with nonusers was reduced by about 50% with the use of more than six canisters per year.

The mean number of canisters used was 1.18 for the patients who died and 1.57 for the controls. Based on their analysis, the researchers calculated that the rate of death from asthma decreased by 21% with each additional canister of inhaled steroids used in the previous year. Furthermore, the death rate from asthma in the first three months after discontinuing steroid use was higher than among patients who continued the drugs.

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.